Influence of anticoagulant concomitant medication on wound healing: Analysis of a multicentre cohort of 212 patients with a uniform wound model
British Journal of Clinical Pharmacology · 2025
DOI: 10.1002/bcp.70073 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Christian Seebauer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery/Plastic Surgery, University Medicine Lübeck, Lübeck, Germany. Hauptthemen laut MEDLINE: Wound Healing, Anticoagulants, Enoxaparin, Nadroparin. Die Arbeit nennt 36 Literaturangaben.
Themen: Wundversorgung
Abstract (Originalsprache)
Aims
Various factors can impair wound healing by disrupting key stages of the process. This study evaluates the impact of concomitant anticoagulant medication on wound healing in a cohort of 212 patients.
Methods
Data from 2 open‐label, blindly evaluated, prospective, randomized, multicentre phase III trials ( n = 212) were analysed. Healing durations of patients taking anticoagulants were compared to a control group (split‐thickness skin graft donor site halves treated with standard moist wound dressing). Kaplan–Meier estimators and multivariable Cox regression were applied.
Results
Kaplan–Meier analysis demonstrated significantly accelerated wound healing in patients treated with enoxaparin or nadroparin. Among monotherapies, 75% of patients on enoxaparin achieved wound closure within 16.5 days (95% confidence interval [CI]: 14–21), and those on nadroparin within 15 days (95% CI: 11.5–19), compared to 24 days (95% CI: 20–28) in patients receiving other anticoagulants (log‐rank test: P < .001). Cox regression confirmed a significantly faster healing rate with enoxaparin or nadroparin (hazard ratio = 1.50, 95% CI: 1.02–2.19, P = .039).
Conclusion
Enoxaparin and nadroparin may enhance wound healing, whereas phenprocoumon, acetylsalicylic acid, and certain low‐molecular‐weight heparins (certoparin, tinzaparin, dalteparin, bemiparin) appear to delay wound healing. Anticoagulant monotherapy with enoxaparin or nadroparin should be considered postoperatively when feasible.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery/Plastic Surgery, University Medicine Lübeck, Lübeck, Germany.
- Department of Oral and Maxillofacial Surgery/Plastic Surgery, University Medicine Greifswald, Greifswald, Germany.
- Institute of Bioinformatics, University Medicine Greifswald, Greifswald, Germany.
ORCID-Profile: Christian Seebauer
Zitieren
APA
Seebauer, C., Hanafieh, F., Wolff, J., Metelmann, H. R., & Vollmer, M. (2025). Influence of anticoagulant concomitant medication on wound healing: Analysis of a multicentre cohort of 212 patients with a uniform wound model. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70073
Vancouver
Seebauer C, Hanafieh F, Wolff J, Metelmann HR, Vollmer M. Influence of anticoagulant concomitant medication on wound healing: Analysis of a multicentre cohort of 212 patients with a uniform wound model. British Journal of Clinical Pharmacology. 2025. doi:10.1002/bcp.70073
BibTeX
@article{Seebauer2025,
author = {Seebauer, Christian and Hanafieh, Fares and Wolff, Jan and Metelmann, Hans-Robert and Vollmer, Marcus},
title = {Influence of anticoagulant concomitant medication on wound healing: Analysis of a multicentre cohort of 212 patients with a uniform wound model},
journal = {British Journal of Clinical Pharmacology},
year = {2025},
doi = {10.1002/bcp.70073}
}
EUVIMED